Schedule 13D ownership disclosure

CYCLO THERAPEUTICS INC

Security class unavailable · CUSIP: 23254X201

Event date: 2023-07-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,157,214
Percent of class
49.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-23-064040
Form type
SC 13D/A
Filer
Cyclo Therapeutics, Inc.
CIK
CIK 922247
Filed
Aug 07, 2023
Reporting period
Jul 31, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub